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Abstract Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder whose
neurodevelopmental symptoms include impaired executive function, attention, and spatial learning
and could be due to perturbed mesolimbic dopaminergic circuitry. However, these circuits have
never been directly assayed in vivo. We employed the genetically encoded optical dopamine
sensor dLight1 to monitor dopaminergic neurotransmission in the ventral striatum of NF1 mice
during motivated behavior. Additionally, we developed novel systemic AAV vectors to facilitate
morphological reconstruction of dopaminergic populations in cleared tissue. We found that NF1
mice exhibit reduced spontaneous dopaminergic neurotransmission that was associated with
excitation/inhibition imbalance in the ventral tegmental area and abnormal neuronal morphology.
NF1 mice also had more robust dopaminergic and behavioral responses to salient visual stimuli,
which were independent of learning, and rescued by optogenetic inhibition of non-dopaminergic
neurons in the VTA. Overall, these studies provide a first in vivo characterization of dopaminergic
circuit function in the context of NF1 and reveal novel pathophysiological mechanisms.
DOI: https://doi.org/10.7554/eLife.48983.001
Introduction
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder of neural crest-derived tissues
that affects approximately 1 in 3500 individuals worldwide and is caused by loss of one functional
copy of the NF1 gene on chromosome 17 (Wallace et al., 1990). Neurofibromin, the protein prod-
uct of NF1, inhibits Ras-dependent cellular growth and proliferation (Basu et al., 1992) and enhan-
ces cAMP signaling pathways (Tong et al., 2002). The clinical features of NF1 include pigmentary
lesions, neoplasia (e.g. cutaneous and plexiform neurofibromas, optic gliomas, malignant peripheral
nerve sheath tumors), cognitive and learning disabilities, peripheral neuropathy, musculoskeletal
abnormalities, and gross and fine motor delays (Cimino and Gutmann, 2018; Gutmann et al.,
2012). Cognitive dysfunction is a significant source of lifetime morbidity, as up to 70% of affected
individuals experience impaired executive functioning, speech and language delays, attention defi-
cits, hyperactivity, and/or impulsivity (Hyman et al., 2005). Furthermore, approximately one third of
patients with NF1 meet DSM-V criteria for attention deficit hyperactivity disorder (ADHD)
(Hyman et al., 2005; Miguel et al., 2015). Despite the societal burden of NF1-associated cognitive
sequelae, their etiology has not been fully elucidated.
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Although homozygous genetic disruption of the Nf1 gene is embryonic lethal in mice (Silva et al.,
1997), cognitive deficits in NF1 have been successfully modeled in several transgenic and condi-
tional knockout mouse lines (Silva et al., 1997; Zhu et al., 2001; Hegedus et al., 2007; Cui et al.,
2008; Brown et al., 2010a; Anastasaki et al., 2015; Omrani et al., 2015; Li et al., 2016; Xie et al.,
2016). Heterozygous knockout mice (Nf1+/-) exhibit impaired spatial learning (Costa et al., 2001;
Silva et al., 1997), which is Ras/ERK-dependent (Costa et al., 2002), rescued by the Ras inhibitor
lovastatin (Li et al., 2005), and may be due to increased inhibitory GABA tone (Costa et al., 2002).
Additionally, the neurofibromin C-terminus is a positive regulator of G-protein-stimulated adenylyl
cyclase activity (Hannan et al., 2006; Tong et al., 2002), and cAMP deficiency in NF1 knockout
models causes altered in vitro neuronal morphology and growth, visual learning deficits, and
changes in cortical architecture in mice (Brown et al., 2012; Brown et al., 2010b; Hegedus et al.,
2007; Wolman et al., 2014). Attenuated dopaminergic neurotransmission in mesolimbic and nigros-
triatal circuits are putative mechanisms underlying attentional, learning, and motivational deficits
observed in NF1 model mice (Diggs-Andrews and Gutmann, 2013). Mesolimbic reward circuits
involve the convergence of dopaminergic projections from the midbrain ventral tegmental area
(VTA) with glutamatergic inputs from cortical and subcortical regions on medium spiny neurons in
the nucleus accumbens (NAc). These circuits facilitate the translation of relevant internal and external
stimuli into motivated behaviors (Wise, 2005) and have been implicated in the pathophysiology of
ADHD and other disorders of impulse control (Li et al., 2006; Purper-Ouakil et al., 2011).
In the optic glioma mouse model of NF1 (OPG, a conditional Nf1 knockout in astrocytes on an
Nf1+/- background), reduced striatal dopamine is associated with motor, exploratory, spatial learn-
ing, and attentional abnormalities (Brown et al., 2010a; Diggs-Andrews et al., 2013;
Anastasaki et al., 2015), which are ameliorated by treatment with the catecholamine re-uptake
eLife digest About one in 3,500 people have a genetic disorder called neurofibromatosis type
1, often shortened to NF1, making it one of the most common inherited diseases. People with NF1
may have benign and cancerous tumors throughout the body, learning disabilities, developmental
delays, curvature of the spine and bone abnormalities. Children with NF1 often experience
difficulties with attention, hyperactivity, speech and language delays and impulsivity. They may also
have autism spectrum disorder, or display symptoms associated with this condition.
Studies in mice with a genetic mutation that mimics NF1 suggest that abnormal development in
cells in the middle of the brain may cause the cognitive symptoms. These midbrain neurons produce
a chemical called dopamine and send it throughout the brain. Dopamine is essential for
concentration and it is involved in how the brain processes pleasurable experiences.
Now, Robinson et al. show that, at rest, the NF1 model mice release dopamine less often than
typical mice. This happens because, when there are no stimuli to respond to, neighboring cells slow
down the activity of dopamine-producing neurons in NF1 model mice.
In the experiments, both NF1 model mice and typical mice were taught to associate
environmental cues with rewards or punishments. Robinson et al. then measured the release of
dopamine in the mice using a sensor called dLight1, which produces different intensities of
fluorescent light depending on the amount of dopamine present. This revealed that the NF1 model
mice produced more dopamine in response to visual cues and had enhanced behavioral responses
to these stimuli. For example, when a looming disc that mimics predators approached them from
above, the NF1 model mice tried to hide in an exaggerated way compared to the typical mice.
Previously, it had been shown that this type of behavior is due to the activity of the dopamine-
producing neurons’ neighboring cells, which Robinson et al. found is greater in NF1 model mice.
Next, Robinson et al. stopped neighboring cells from interfering with the dopamine-producing
neurons in NF1 model mice. This restored dopamine release to normal levels at rest, and stopped
the mice from overreacting to the looming disc. The experiments help explain how the NF1 model
mice process visual information. Further study of the role dopamine plays in cognitive symptoms in
people with NF1 may help scientists develop treatments for the condition.
DOI: https://doi.org/10.7554/eLife.48983.002
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inhibitor methylphenidate or the dopamine precursor L-DOPA (Brown et al., 2010a). Despite these
efforts, dopaminergic neurotransmission has never been investigated in NF1 models in vivo. In order
to address this gap in the understanding of NF1, we utilized the new, ultra-fast, genetically encoded
dopamine sensor dLight1 (Patriarchi et al., 2018) to monitor dopamine dynamics in the lateral
nucleus accumbens (LNAc) during motivated behavior in 129T2/SvEmsJ::C57Bl/6NTac F1 hybrid Nf1
wildtype (Nf1+/+) and heterozygous knockout (Nf1+/-) mice. This hybrid background produces more
robust behavioral phenotypes than those on a pure C57Bl/6 background (Cui et al., 2008; Li et al.,
2005; Shilyansky et al., 2010). Novel dopaminergic phenotypes were further parsed with patch
clamp electrophysiology and optogenetics. Because previous morphological analysis has largely
been restricted to neuronal cultures (Brown et al., 2010a; Anastasaki et al., 2015), we comprehen-
sively characterized dopaminergic neuron structure in situ in Nf1+/+ and Nf1+/- mice using tissue
clearing, tracing methods, and the novel systemic AAV-based tool Th-VAST (catecholaminergic neu-
ron-targeted vector-assisted spectral tracing). These efforts revealed distinct dopaminergic pheno-
types, identified putative mechanisms governing their expression, and explored how Nf1
haploinsufficiency moderates the motivational salience of relevant environment stimuli.
Results
In vivo optical monitoring of dopaminergic neurotransmission using
dLight1.2
In order to investigate dopamine dynamics in freely behaving Nf1+/+ and Nf1+/- mice, we utilized the
genetically encoded, fluorescent dopamine sensor dLight1.2 (Patriarchi et al., 2018), which allows
for sub-micromolar detection of extracellular dopamine concentrations with sub-second resolution
and negligible sensitivity to other monoamines, GABA, and glutamate (Corre et al., 2018;
Patriarchi et al., 2018). Fluorescent dopamine signals in the LNAc were monitored with fiber pho-
tometry (Gunaydin et al., 2014); this terminal field region was chosen because its afferent ventral
tegmental dopaminergic inputs exhibit a high diversity of responses to both rewarding and aversive
stimuli and stimulus-predictive cues (de Jong et al., 2019; Lammel et al., 2011). To facilitate optical
dopamine measurements, an adeno-associated viral vector (AAV9-hSyn-dLight1.2) was stereotaxi-
cally injected into the LNAc to express dLight1.2 in neurons, followed by implantation of a 400 mm
optical fiber (Figure 1A) for sensor excitation and emitted photon collection via a custom photome-
try system (Cho et al., 2017) (Figure 1B).
After surgical recovery, we measured baseline differences in spontaneous dopaminergic neuro-
transmission by monitoring dLight1.2 signals (Figure 1C, Figure 1—figure supplement 1) in the
LNAc during 5-min epochs in which mice sat in a dark, sound-attenuating chamber. Peak analysis
was performed to identify local trace prominences (Figure 1D) and revealed that the dopamine tran-
sient event rate was reduced in Nf1+/- mice compared to Nf1+/+ littermates (Figure 1E). Baseline
(median) fluorescence, peak amplitude, and full width at half maximal intensity (FWHM) was equiva-
lent between genotypes. Because reduced LNAc dopamine content and afferent terminal TH
expression have been observed in OPG mice (Brown et al., 2010a; Diggs-Andrews et al., 2013),
we measured monoamine and monoamine metabolite levels in the NAc using high-performance liq-
uid chromatography. We failed to detect differences in dopamine (DA), serotonin (5-HT), norepi-
nephrine (NE), or their metabolites between genotypes (Figure 1—figure supplement 2).
Additionally, there was no difference in dopaminergic terminal tyrosine hydroxylase expression
across striatal sub-compartments (Figure 1—figure supplement 2). These findings suggest that
basal differences in dLight1.2 event rate are not due to changes in dopaminergic terminal density or
dopamine synthetic capacity.
In order to further parse differences in spontaneous dopaminergic transient activity, we per-
formed whole-cell patch clamp electrophysiological recordings in acute midbrain slices that con-
tained the lateral ventral tegmental area (Figure 1F), which is the main source of dopaminergic
projections to the LNAc (Lammel et al., 2011). Because the dependence of Nf1+/- phenotypes on
genetic background precludes crossing with cell-type-specific reporter or Cre recombinase lines, we
used a blood-brain barrier penetrant, systemic adeno-associated viral vector (AAV-PHP.eB)
(Chan et al., 2017) containing a green fluorescent protein (GFP) transgene under control of the rat
tyrosine hydroxylase promoter (Oh et al., 2009) (AAV-PHP.eB-Th-GFP; 1  1011 viral genomes/
Robinson et al. eLife 2019;8:e48983. DOI: https://doi.org/10.7554/eLife.48983 3 of 30
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Figure 1. Assessment of basal dopaminergic function in vivo with dLight1.2 and ex vivo patch clamp electrophysiology. (A) Illustration showing location
of stereotaxic injection of the AAV9-hSyn-dLight1.2 viral vector and photometry fiber implantation (left). Representative histological image (right, scale:
300 mm) showing the fiber tip location and expression of dLight1.2 (stained for GFP, green) and dopaminergic terminal tyrosine hydroxylase (TH, Red).
(B) Schematic of fiber photometry system used for dLight1.2 (490 nm) and isosbestic (405 nm; reference signal) excitation and emission signal detection
in freely moving mice. (C) Representative dLight1.2 traces in Nf1+/+ and Nf1+/- mice. (D) Representative trace and analysis features for baseline peak
detection. (E) Peak analysis of baseline dLight1.2 recordings revealed that Nf1+/- mice (n = 33) exhibit reduced transient frequency (unpaired t-test;
t50 = 3.06, p=0.004) but not median fluorescence (unpaired t-test; t50 = 1.01, p=0.32), transient amplitude (unpaired t-test; t50 = 0.83, p=0.41), or full
width at half maximal amplitude (FWHM; unpaired t-test; t50 = 0.43, p=0.67) when compared to Nf1
+/+ littermates (n = 19). (F) 4X differential
interference contrast (DIC) image (left) of an acute horizontal midbrain slice containing the ventral tegmental area (VTA) and 4X epifluorescence image
(right) with GFP-labeled catecholaminergic neurons following systemic delivery of AAV-PHP.eB-Th-GFP (1  1011 v.g./mouse). (G) Representative traces
showing spontaneous whole-cell firing of putative VTA dopaminergic neurons (left). Spontaneous firing rates (right) were lower (unpaired t-test;
t28 = 2.58, p=0.0 w) in Nf1
+/- putative dopaminergic neurons (n = 18) compared to Nf1+/+ neurons (n = 12). (H) Representative electrophysiological
traces (left) showing evoked firing by a 1 pA/ms ramp current from  60 mV in Nf1+/+ and Nf1+/- putative dopaminergic neurons. Rheobase (right;
unpaired t-test; t48 = 4.05, p<0.001) but not action potential threshold (I; t48 = 1.93, p=0.06) or width (J; t48 = 0.39, p=0.70) was increased in Nf1
+/-
(n = 29) putative dopaminergic neurons compared to Nf1+/+ (n = 21). *denotes p<0.05 vs Nf1+/+. Data presented as mean ± SEM.
DOI: https://doi.org/10.7554/eLife.48983.003
The following figure supplements are available for figure 1:
Figure supplement 1. Raw fluorescent photometry signals.
DOI: https://doi.org/10.7554/eLife.48983.004
Figure supplement 2. Striatal catecholamine content and tyrosine hydroxylase immunofluorescence.
DOI: https://doi.org/10.7554/eLife.48983.005
Robinson et al. eLife 2019;8:e48983. DOI: https://doi.org/10.7554/eLife.48983 4 of 30
Research article Neuroscience
mouse r.o.; Figure 1F, right) to label dopaminergic neurons. This allowed for visual identification
during patch clamp experiments. GFP-positive cells were considered to be dopaminergic if their
action potential duration was >1 ms, a previously validated threshold to distinguish dopaminergic
from GABAergic neurons in the VTA (Chieng et al., 2011). We found that putative dopaminergic
neurons in Nf1+/- midbrain slices exhibited lower spontaneous whole-cell firing rates (Figure 1G)
and required more rheobase current to elicit a spike when compared to Nf1+/+ neurons (Figure 1H).
This finding supports the hypothesis that phenotypic differences in baseline dLight1.2 event metrics
are activity-dependent. Action potential threshold, duration, amplitude, and after hyperpolarization
magnitude did not differ between genotypes (Figure 1I–J, Table 1).
Morphological characterization of VTA dopaminergic neurons in Nf1+/+
and Nf1+/- mice
During whole-cell recordings, we also observed that Nf1+/- putative dopaminergic neurons exhibit
increased input resistance (Rm) and decreased membrane capacitance (Cm) compared to Nf1
+/+ lit-
termates (Figure 2A) without a change in other membrane properties (Table 2). This finding was
robust across experiments (Table 2). Because increased Rm could be indicative of reduced soma vol-
ume (Torres-Torrelo et al., 2014), we manually traced over two thousand TH-positive dopaminergic
somata in the VTA per genotype (Figure 2B). We found that cross-sectional area, major axis length,
and minor axis length were reduced in Nf1+/- mice (Figure 2C–D, Figure 2—figure supplement 1).
Proportionality was maintained, however, as the soma aspect ratio was equivalent between geno-
types (Figure 2—figure supplement 1). TH immunofluorescence and total neuron counts in the VTA
did not differ between Nf1+/- and Nf1+/+ dopaminergic neurons (Figure 2D). No phenotypic differ-
ences were observed in the adjacent substantia nigra pars compacta (Figure 2—figure supplement
1). These findings indicate that relative differences in soma size were VTA-specific and could have
contributed to changes in passive membrane properties.
Dendritic complexity also contributes to cell input resistance (Bekkers and Hausser, 2007;
Sˇisˇkova´ et al., 2014), so we modified the two-component, systemic AAV-based method VAST (Vec-
tor-Assisted Spectral Tracing) (Chan et al., 2017) to create Th-VAST. This tool facilitates anatomical
reconstruction of dendritic arbors by providing recombinase-independent, sparse, multicolor label-
ing of catecholaminergic neurons. VAST achieves hue diversity via stochastic expression of three tet-
racycline response element (TRE)-regulated fluorescent proteins (XFPs; mRuby2, mNeonGreen, and
mTurquoise2) following systemic delivery with AAV-PHP.eB. Sparseness is subsequently tuned by
titration of a co-delivered, tet-off transactivator (tTA) inducer vector (Chan et al., 2017). In Th-VAST,
tTA expression is targeted to catecholaminergic neurons via use of the Th promoter, and retro-
orbital delivery of the XFP cocktail (AAV-PHP.eB-TRE-XFP; 1  1012 vg/mouse total) and the inducer
vector (AAV-PHP.eB-Th-tTA; 1  1011 vg/mouse) produced dense multicolor labeling of Th neurons
Table 1. Action potential features across patch clamp electrophysiology experiments.
Property Experiment p +/+: Mean ± SEM, n +/-: Mean ± SEM, n
Rheobase Baseline characterization <0.001 124.1 ± 8.65 pA, n = 21 171.7 ± 7.779 pA, n = 29
AP Threshold Baseline characterization 0.059  39.32 ± 1.266 mV, n = 21  36.45 ± 0.8708 mV, n = 29
AP Duration Baseline characterization 0.695 3.671 ± 0.2525 ms, n = 21 3.562 ± 0.1499 ms, n = 29
AP Height Baseline characterization 0.555 60.89 ± 1.607 mV, n = 21 59.42 ± 1.749 mV, n = 29
AP AHP Baseline characterization 0.897  15.43 ± 1.19 mV, n = 21  14.88 ± 1.046 mV, n = 29
Firing Rate Baseline characterization 0.016 2.633 ± 0.2464 Hz, n = 12 1.703 ± 0.244 Hz, n = 18
Rheobase Picrotoxin rescue <0.001 131.5 ± 7.537 pA, n = 25 89.14 ± 6.413 pA, n = 20
AP Threshold Picrotoxin rescue 0.456  36.92 ± 1.193 mV, n = 25  38.33 ± 1.472 mV, n = 20
AP Duration Picrotoxin rescue 0.610 4.156 ± 0.1589 ms, n = 25 4.03 ± 0.1891 ms, n = 20
AP Height Picrotoxin rescue 0.946 56.16 ± 2.021 mV, n = 25 55.99 ± 1.151 mV, n = 20
AP AHP Picrotoxin rescue 0.168  13.84 ± 1.125 mV, n = 25  11.78 ± 0.844 mV, n = 20
Firing Rate Picrotoxin rescue 0.714 2.434 ± 0.208 Hz, n = 16 2.535 ± 0.1596 Hz, n = 13
DOI: https://doi.org/10.7554/eLife.48983.006
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Figure 2. Morphological analysis of ventral tegmental dopaminergic neurons in Nf1+/+ and Nf1+/- mice. (A) Whole-cell recordings revealed that Nf1+/-
putative dopaminergic neurons (n = 29) had increased input resistance (Rm; left; unpaired t-test; t48 = 2.97, p=0.005) and decreased capacitance (Cm;
right; t48 = 2.54, p=0.01) compared to Nf1
+/+ neurons (n = 21). (B) Representative ventral midbrain images containing the ventral tegmental area (VTA)
and substantia nigra pars compacta (SNc) stained for tyrosine hydroxylase (TH, scale: 300 mm); TH-positive neurons in the VTA (inset, scale: 100 mm). (C)
The cumulative probability distribution of the cross sectional area of manually traced Nf1+/+ (n = 2344) and Nf1+/- (n = 2586) VTA dopaminergic neuron
somata (two-sample Kolmogorov-Smirnov test; D = 0.18, p<0.001). (D) Average VTA dopaminergic soma area (left; n+/+ = 17, n+/- = 15; unpaired t-test;
t30 = 4.65, p<0.001), TH immunofluorescence (middle; t30 = 0.25, p=0.90), and number of neurons/histological section (right; t30 = 0.15, p=0.88) per
mouse. (E) Th-VAST (left) produced multicolor labeling of dopaminergic neurons in the VTA (middle, scale: 300 mm; right, scale: 100 mm). (F) Dense (left,
scale: 20 mm) or sparse multi-color labeling (right, scale: 20 mm) was achieved via retro-orbital injection of either 1  1011 or 6  109 vg/mouse AAV-
PHP.eB-Th-tTA, respectively, and 1  1012 total vg/mouse of the XFP cocktail (AAV-PHP.eB-TREx7-mRuby2, -mNeonGreen, or -mTurquoise2). (G)
Representative dopaminergic neuron reconstructions following neurite tracing (scale: 20 mm). (H) Sholl analysis failed to detect a difference in dendritic
complexity (left; two-way repeated measures ANOVA; F80,2160 = 0.052, pdistance x genotype >0.99; F80,2160 = 63.9, pdistance <0.001; F1,27 = 0.25,
pgenotype = 0.63) or total neurite length (right; unpaired t-test; t27 = 0.18, p=0.86) between genotypes (n+/+ = 13, n+/- = 16 for +/- group). * denotes
p<0.05 vs Nf1+/+. Data presented as mean ± SEM.
DOI: https://doi.org/10.7554/eLife.48983.007
The following figure supplements are available for figure 2:
Figure supplement 1. Additional data: histological analysis.
DOI: https://doi.org/10.7554/eLife.48983.008
Figure supplement 2. Additional data: Th-VAST.
DOI: https://doi.org/10.7554/eLife.48983.009
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in the VTA and SNc (Figure 2E–F, Figure 2—figure supplement 2). Compared to 1  1012 vg/
mouse AAV-PHP.eB-Th-GFP (Chan et al., 2017), the specificity of Th-VAST vectors was lower in the
VTA (58.7% vs 81%) and SNc (74.2% vs 81%) (Figure 2—figure supplement 2) despite good XFP
restriction to these areas. This likely occurred because induction of XFP expression requires very low
levels of tTA, and a sub-population of VTA projection neurons have hybrid Th-GABAergic pheno-
types (Root et al., 2014; Stuber et al., 2015). As such, spectral tracing was only performed when
Th-VAST-labeled neurons were unequivocally tyrosine hydroxylase-positive.
Using a lower inducer vector dose (6  109 vg/mouse) to provide sparse labeling (Figure 2F,
right), we repeated Th-VAST in Nf1+/- and Nf1+/+ mice. Following two weeks of expression, we pre-
pared and optically cleared (using RIMS) (Yang et al., 2014) 300 mm horizontal VTA sections that
had been immunostained for TH to confirm post hoc that Th-VAST-labeled neurons were dopami-
nergic. After tracing in Imaris (Figure 2G), Sholl analysis was performed to quantify dendritic branch-
ing by detecting neurite intersections with concentric 5 mm shells originating from the soma. No
difference in dendritic complexity or total neurite length was observed between genotypes
(Figure 2H), which suggests that, although Nf1+/- dopaminergic neurons have smaller somata than
Nf1+/+ neurons, they have similar neurite morphology.
Nf1+/- putative dopaminergic neurons exhibit excitation/inhibition
imbalance in the ventral tegmental area
The observation that Nf1+/- dopaminergic neurons have reduced cross-sectional areas but higher
rheobase requirement was unexpected, given that smaller neurons tend to be more excitable
(Torres-Torrelo et al., 2014). In order to parse these differences, we first assayed dopaminergic Ih
currents, which contribute to the stability of spontaneous firing rates (Neuhoff et al., 2002;
Seutin et al., 2001) and are attenuated in hippocampal interneurons in NF1 model mice
(Omrani et al., 2015). Ih was determined by quantifying the sag current produced by a series of
hyperpolarizing voltage steps from  60 mV to  130 mV in voltage clamp (Figure 3A). We found
that Nf1+/- dopaminergic neurons had smaller Ih current amplitudes (Figure 3A, Figure 3—figure
supplement 1) without a change in voltage dependence (Figure 3B; determined by tail current anal-
ysis) relative to Nf1+/+ littermates. Differences in Ih current amplitudes were not significant when nor-
malized to the cell capacitance to account for cell size (Figure 3C, Figure 3—figure supplement 1),
and maximum Ih current amplitude was significantly correlated with Cm across all animals and within
genotypes (Figure 3D). Since reduced cAMP production, which has been associated with Nf1+/- neu-
ronal phenotypes in vitro (Brown et al., 2012), could attenuate the Ih current, we repeated Ih meas-
urements in Nf1+/- slices in the presence of the adenylyl cyclase activator forskolin. Addition of 20
mM forskolin to the bath solution did not significantly affect Ih magnitude or voltage dependence in
Nf1+/- putative dopaminergic neurons (Figure 3—figure supplement 1). Thus, changes in Ih
Table 2. Passive membrane properties across patch clamp electrophysiology experiments.
Property Experiment p +/+: Mean ± SEM, n +/-: Mean ± SEM, n
Cm Baseline characterization 0.014 47.35 ± 2.032 pF, n = 21 41.27 ± 2.026 pF, n = 29
Rm Baseline characterization 0.005 172.4 ± 10.94 MW, n = 21 235.7 ± 16.32 MW, n = 29
Rs Baseline characterization 0.966 17.86 ± 1.73 pF MW, n = 21 17.95 ± 1.257 MW, n = 29
Holding Baseline characterization 0.658  74.26 ± 10.95 pA, n = 21  81.01 ± 10.18 pA, n = 29
Cm Ihmeasurement 0.047 51.94 ± 4.45 pF, n = 14 42.53 ± 2.351 pF, n = 24
Rm Ihmeasurement 0.009 170.8 ± 11.96 MW, n = 14 222.4 ± 12.49 MW, n = 24
Rs Ihmeasurement 0.528 17.78 ± 1.478 MW, n = 14 19.1 ± 1.334 MW, n = 24
Holding Ihmeasurement 0.457  61.15 ± 8.657 pA, n = 14  52.11 ± 7.642 pA, n = 24
Cm Picrotoxin rescue 0.004 47.74 ± 2.276 pF, n = 29 36.62 ± 2.956 pF, n = 20
Rm Picrotoxin rescue 0.001 181 ± 8.464 MW, n = 29 239 ± 14.94 MW, n = 20
Rs Picrotoxin rescue 0.670 17.23 ± 1.054 MW, n = 29 18.04 ± 1.648 MW, n = 20
Holding Picrotoxin rescue 0.611  56.77 ± 5.88 pA, n = 29  61.64 ± 7.639 pA, n = 20
DOI: https://doi.org/10.7554/eLife.48983.010
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magnitude are likely cAMP-independent, reflective of smaller cell size, and unlikely to be the etio-
logic cause of reduced cell excitability.
Excitation/inhibition imbalance due to increased GABAergic tone is a hypothesized mechanism
governing NF1-associated cognitive deficits (Diggs-Andrews and Gutmann, 2013), and GABAA
receptor agonists increase rheobase (Rojas et al., 2011), so we investigated excitation/inhibition
balance in putative dopaminergic neurons by measuring spontaneous inhibitory (sIPSC) and excit-
atory post-synaptic currents (sEPSC) in voltage clamp (Figure 3E). We found that Nf1+/- putative
dopaminergic neurons displayed increased sIPSC frequency but not sIPSC amplitude, sEPSC
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Figure 3. Electrophysiological characterization of Ih, inhibitory, and excitatory currents in VTA dopaminergic neurons ex vivo. (A) Representative traces
showing Ih currents during hyperpolarizing voltage steps from  60 to  130 mV. (B) Ih current magnitude was smaller (2-way repeated measures ANOVA
with Bonferroni post hoc tests; F7,252 = 5.38, pgenotype x voltage <0.001) in Nf1
+/- putative dopaminergic neurons (n = 24) compared to Nf1+/+ neurons
(n = 14). (B) Tail current analysis showed no difference in the Ih voltage dependence between Nf1
+/+ (n = 14, EV50 =  96.98 mV, 95% CI =  99.69 to
 94.52 mV) and Nf1+/- putative dopaminergic neurons (n = 24, EV50 =  101.9 mV, 95% CI =  106.5 to  98.86 mV). (C) Maximum Ih current density did
not differ between Nf1+/+ (n = 14) and Nf1+/- (n = 24) putative dopaminergic neurons (unpaired t-test; t36 = 1.56, p=0.13). (D) Ih magnitude was
negatively correlated with Cm in Nf1
+/+ (R2 = 0.39, p=0.02), Nf1+/- (R2 = 0.17, p=0.049), and across all putative dopaminergic neurons (R2 = 0.35,
p<0.001). (E) Representative traces of spontaneous excitatory (sEPSC) and inhibitory (sIPSC) post-synaptic currents. (F) The frequency of sIPSCs (n+/+ =
18, n+/- = 17; Mann-Whitney U test; U = 74.5, p=0.009; unpaired t-test; t33 = 2.20, p=0.03) but not sEPSCs (n+/+ = 15, n+/- = 13; U = 87.0, p=0.65;
t26 = 0.19, p=0.85) was lower in Nf1
+/- putative dopaminergic neurons. (G) Amplitude of sIPSCs (n+/+ = 18, n+/- = 17; U = 96.5, p=0.06; t33 = 1.63,
p=0.11) and sEPSCs (n+/+ = 15, n+/- = 13; U = 90.0, p=0.75; t26 = 0.07, p=0.94). (H) 100 mM picrotoxin rescued spontaneous firing of Nf1
+/- putative
dopaminergic neurons (n+/+ = 16, n+/- = 13; two-way ANOVA with Bonferroni post hoc tests; F1,55 = 5.18, pgenotype x drug = 0.03; control: p+/+ vs +/- =
0.03, picrotoxin: p+/+ vs +/- > 0.99) relative to control neurons (n+/+ = 12, n+/- = 18) and (I) lowered rheobase (n+/+ = 25, n+/- = 20) relative to control
Nf1+/- neurons (n+/+ = 21, n+/- = 24; F1,91 = 30.0, pgenotype x drug <0.001; control: p+/+ vs +/- < 0.001, picrotoxin: p+/+ vs +/- = 0.003, Nf1
+/-: pcontrol vs
picrotoxin <0.001). * denotes p<0.05 vs Nf1
+/+. # denotes p<0.05 vs control. Data presented as mean ± SEM, except box plots in F-G.
DOI: https://doi.org/10.7554/eLife.48983.011
The following figure supplements are available for figure 3:
Figure supplement 1. Effect of 20 mM forskolin (FSK) on putative dopaminergic neuron Ih currents.
DOI: https://doi.org/10.7554/eLife.48983.012
Figure supplement 2. Effect of 5 mg/kg morphine sulfate on spontaneous dLight1.2 transients in Nf1+/- mice.
DOI: https://doi.org/10.7554/eLife.48983.013
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Figure 4. In vivo optical monitoring of dopamine dynamics during reward consumption and Pavlovian conditioning. (A) Consumption of 5% sucrose
evoked robust, time-locked fluorescent dopamine transients in both Nf1+/+ (left) and Nf1+/- mice (right). (B) Peak dLight1.2 responses to the onset
sucrose consumption (n+/+ = 13, n+/- = 13; unpaired t-test; t24 = 0.66, p=0.51). (C) No difference in total number of licks (left; t24 = 1.33, p=0.20) or licks
per bout (right; t24 = 0.14, p=0.89) were observed between genotypes. (D) Average session-by-session reward seeking during Pavlovian conditioning;
the unconditioned stimulus (US, 5% sucrose) was delivered 7 s after the onset of a reward-predictive 10 s conditioned stimulus (CS, 5 kHz tone with
house light illumination). (E) Nf1+/+ (n = 10) and Nf1+/- (n = 12) mice displayed learned licking during the CS that was not dependent on genotype (two-
way repeated measures ANOVA; F9,180 = 0.48, pgenotype x session = 0.89; F9,180 = 21.36, psession <0.001; F1,20 = 0.09, pgenotype = 0.77). (F) Individual
averaged dLight1.2 traces before (left, Session 1) and after (right, Session 10) learning showing CS, US, and pump responses. (G) Heatmap showing
average dLight1.2 responses to the CS (left; two-way repeated measures ANOVA; peak response: F9,180 = 0.81, pgenotype x session = 0.61) or US (right;
peak response: F9,180 = 0.49, pgenotype x session = 0.88) across training sessions. (H) Across sessions, the rate of acquisition of licking during the CS was
correlated with the rate of change of the CS (Nf1+/+: R2 = 0.48, p=0.03; Nf1+/-: R2 = 0.52, p=0.008) and US peak (Nf1+/+: R2 = 0.63, p=0.006; Nf1+/-:
R2 = 0.36, p=0.03) in both genotypes. (I) Unexpected omission resulted in a significant reduction in US magnitude in both Nf1+/+ (n = 10; paired t-test;
t9 = 4.03, p=0.003) and Nf1
+/+ mice (n = 12; paired t-test; t11 = 4.50, p<0.001). (J) Correlation between CS peak response and CS licking during session
1 (Nf1+/+: R2 = 0.25, p=0.14; Nf1+/-: R2 = 0.16, p=0.21; pgenotype = 0.04; inset: average peak; unpaired t-test; t20 = 2.34, p=0.03), session 2 (Nf1
+/+:
R2 = 0.008, p=0.80; Nf1+/-: R2 = 0.22, p=0.12; pgenotype = 0.14), session 4 (Nf1
+/+: R2 = 0.28, p=0.12; Nf1+/-: R2 = 0.30, p=0.07; pgenotype = 0.26), and
session 10 (Nf1+/+: R2 = 0.63, p=0.006; Nf1+/-: R2 = 0.46, p=0.02; pgenotype = 0.006). * denotes p<0.05. Data presented as mean ± SEM.
DOI: https://doi.org/10.7554/eLife.48983.015
The following figure supplements are available for figure 4:
Figure supplement 1. dLight1.2 responses to social interaction and measurement of social preference.
DOI: https://doi.org/10.7554/eLife.48983.016
Figure supplement 2. Additional data: Pavlovian conditioning.
DOI: https://doi.org/10.7554/eLife.48983.014
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frequency, or sEPSC amplitude compared to Nf1+/+ neurons (Figure 3F–G). Addition of 100 mM pic-
rotoxin (a highly selective, non-competitive GABAA receptor antagonist) to the bath solution rescued
spontaneous firing rates in Nf1+/- putative dopaminergic neurons (Figure 3H) without affecting pas-
sive membrane properties (Table 2). Picrotoxin also reduced rheobase to levels significantly lower
than control- and picrotoxin-treated Nf1+/+ cells (Figure 3I), which would be expected at baseline
due to differences in soma volume.
Given these findings, we next sought to determine if pharmacological inhibition of VTA GABAer-
gic neurons was sufficient to rescue dLight1.2 transient rates in Nf1+/-mice. m-opioid receptor (MOR)
agonists, such as morphine or DAMGO, robustly increase dopaminergic neuron firing and NAc
dopamine release via pre-synaptic inhibition of GABAergic neurotransmission in the VTA
(Badiani et al., 2011; Di Chiara and Imperato, 1988; Johnson and North, 1992). This model is sup-
ported by recent efforts by Lu¨scher and colleagues that combined NAc dLight1 monitoring and
optogenetic manipulation of VTA sub-populations to examine cell-type-specific substrates of heroin
(diacetylmorphine) reinforcement (Corre et al., 2018). We found that pre-treating Nf1+/- mice with
the mu opioid receptor agonist morphine sulfate (5 mg/kg, s.c.) raised spontaneous dLight1.2 tran-
sient event rate but not event magnitude or FWHM relative to saline (Figure 3—figure supplement
2). This elevated event rate following MOR agonist exposure (0.54 ± 0.03 Hz) was not statistically dif-
ferent (unpaired t-test; t26 = 1.08, p=0.29) from the spontaneous event rate in Nf1
+/+ mice
(0.50 ± 0.02 Hz). Thus, excitation/inhibition imbalance is a mechanism gating Nf1+/- dopaminergic
excitability ex vivo, and attenuation of VTA GABAergic neurotransmission normalizes spontaneous
LNAc dopaminergic neurotransmission in vivo.
Optical monitoring of dopamine responses to conditioned and
unconditioned rewards
After measuring dLight1.2 signals at baseline and parsing these differences ex vivo, we next probed
dopaminergic responses to salient stimuli. Because dopaminergic circuits respond strongly to
rewards and reward-predictive cues (Schultz et al., 2015), we monitored LNAc dopamine signals in
water-restricted mice during consumption of 5% sucrose. In both Nf1+/- and Nf1+/+ mice, we
observed robust LNAc dopamine transients time-locked to reward consumption (Figure 4A) that
were not significantly different between genotypes (Figure 4B). No difference in the number of
rewards consumed during the 30 min session was observed between groups (Figure 4C). We next
measured the dLight1.2 response to social interaction, which is a positive reinforcer in mice
(Martin and Iceberg, 2015). We observed large transients at the onset of interaction with a novel,
sex-matched, juvenile conspecific that was independent of genotype (Figure 4—figure supplement
1). Nf1+/- and Nf1+/+ littermates also failed to display differences in preference for a novel mouse in
a social preference task (Figure 4—figure supplement 1). These findings suggest that LNAc dopa-
mine and behavioral responses to unconditioned rewards are preserved in the context of Nf1
haploinsufficiency.
Dopaminergic populations have been widely studied for their role in reward learning (Keiflin and
Janak, 2015; Schultz et al., 2015; Wise, 2004), so we optically monitored dopaminergic neuro-
transmission during a Pavlovian conditioning assay in water-restricted Nf1+/+ and Nf1+/- mice. In this
task, a 5% sucrose reward (the unconditioned stimulus or US) was delivered seven seconds after the
beginning of a ten-second reward-predictive cue or conditioned stimulus (the CS; a 5 kHz tone with
house light illumination) during ten, twenty-trial sessions. As each mouse learned the cue-reward
association, the number of licks during CS presentation increased across sessions (Figure 4D). No
differences in the number of licks during the CS, the number of anticipatory licks, or the learning
rate (the slope of the linear fit of CS licks across trials) were observed between Nf1+/+ and Nf1+/-
mice (Figure 4E, Figure 4—figure supplement 2). In both genotypes, dLight1.2 peaks were
observed in response to both CS presentation and US consumption (Figure 4F), and in later trials,
to the sound of the sucrose delivery pump (Figure 4—figure supplement 2). Similar to previous
studies (Patriarchi et al., 2018), dLight1.2 responses to the CS and US (Figure 4G) were enhanced
and diminished, respectively, in mice that successfully learned the cue-reward association (i.e. the
learning rate was correlated with the rate of change of each feature peak across trials; (Figure 4H,
Figure 4—figure supplement 2). Unexpected omission of the US following CS presentation after
learning equivalently diminished the dopamine response to reward seeking in both Nf1+/- and
Robinson et al. eLife 2019;8:e48983. DOI: https://doi.org/10.7554/eLife.48983 10 of 30
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Nf1+/+ mice (Figure 4I), which is consistent with the role of dopamine in reward prediction error
detection (Schultz et al., 2015).
Nf1+/- mice displayed enhanced dLight1.2 responses to CS presentation on the first day of testing
(Figure 4J, inset) compared to Nf1+/+ littermates that was largest during the first trial (Figure 4—
figure supplement 2). This phenotypic difference attenuated over subsequent days and re-emerged
as the CS response became correlated with performance (Figure 4J, Figure 4—figure supplement
2). The magnitude of the CS response on the first day of testing did not predict task performance in
later sessions (Session one vs Session 10; Nf1+/+: R2 = 0.02, p=0.69; Nf1+/-: R2 = 0.0006, p=0.94).
Across sessions, a significant main effect of genotype on US magnitude was observed, although US
magnitude was only greater in Nf1+/- mice during session 3 (Figure 4—figure supplement 2). No
differences in response to the sucrose delivery pump, a purely auditory CS, were observed between
genotypes across sessions (Figure 4—figure supplement 2). These findings indicate that, although
CS responses are larger in Nf1+/- mice, the ability to form cue-reward associations is equivalent
between genotypes and coincides with adaptive changes in dopaminergic neurotransmission with
learning.
Optical monitoring of dopaminergic neurotransmission during cued fear
conditioning
Mesolimbic dopaminergic neurons are a heterogeneous population that exhibit diverse response
profiles during exposure to aversive stimuli (Ilango et al., 2012; de Jong et al., 2019;
Lammel et al., 2014), so we next recorded dopamine dynamics in a subset of mice undergoing
cued fear conditioning. In this 15-trial assay, a 10 s audiovisual CS (house light and 3 kHz tone) pre-
dicted a 1 s foot shock (US), and the development of freezing during CS presentation was used as a
proxy for learning. A previous study (Silva et al., 1997) failed to detect differences in cued fear con-
ditioning between Nf1+/+ and Nf1+/- mice, so we employed smaller shock (0.4 mA vs. 0.75 mA) and
tone intensities (60 dB vs. 85 dB), shorter CS (10 s vs. 30 s) and US durations (1 vs. 2 s), and a
repeated trial structure (15 trials vs one trial) in order to avoid a ceiling affect. Over the course of fif-
teen CS-US pairings, both Nf1+/+ and Nf1+/- mice exhibited trial-by-trial increases in freezing during
the first seven trials that subsequently plateaued (Figure 5A). In both genotypes, the expression of
freezing in later trials (average freezing time, trials 8–15) was correlated with the acquisition rate
(slope of the linear fit, trials 1–7; Figure 5B) and the latency to freeze (trials 8–15; Figure 5—figure
supplement 1).
Compared to Nf1+/+ littermates, both the acquisition rate and average freezing time was lower in
Nf1+/- mice, which could be accounted for by an increased latency to freeze (Figure 5C). Qualitative
review of behavioral video recordings revealed that presentation of the CS resulted in several sec-
onds of locomotor stimulation in Nf1+/- mice that delayed freezing (Video 1), whereas Nf1+/+ mice
froze with short latency at CS onset once learning had occurred (Video 2). During LNAc dLight1.2
monitoring, a dopamine transient was observed at the onset of CS presentation that was greatest in
trial 1, attenuated across trials, and was larger in Nf1+/- mice (Figure 5D–E). In Nf1+/- but not Nf1+/+
mice, the magnitude of the CS peak during trial one was negatively correlated with acquisition rate
and freezing duration and positively correlated
with latency to freeze (Figure 5F–G,
Supplementary file 1). During US (shock) deliv-
ery, we observed an initial positive dopamine
transient followed by a 1 to 2 s negative anti-
peak and a subsequent, broader post-US
rebound that returned to baseline several sec-
onds later (Figure 5D,H). This waveform mirrors
patterns of activity observed during extracellular
recordings in the VTA (Brischoux et al., 2009)
and GCaMP monitoring of dopaminergic axons
in the LNAc (de Jong et al., 2019).
During US exposure, Nf1+/- mice had signifi-
cantly larger initial US peak responses and a
smaller integrated post-US rebound compared to
Nf1+/+ littermates (area under the curve;
Video 1. Behavioral response of Nf1+/- mouse to CS
presentation during fear conditioning.
DOI: https://doi.org/10.7554/eLife.48983.019
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Figure 5. In vivo optical monitoring of dopamine dynamics during cued fear conditioning. (A) During the cued fear conditioning assay, mice displayed
a trial-by-trial increase in freezing that was greater in Nf1+/+ mice but not dependent on genotype (n+/+ = 13, n+/- = 18; 2-way repeated measures
ANOVA; F14,406 = 1.321, pgenotype x trial = 0.19; F14,406 = 28.56, ptrial <0.001; F1,29 = 18.54, pgenotype <0.001). (B) The freezing acquisition rate during trials
1–7 was correlated with freezing during trials 8–15 in both Nf1+/+ (n = 13; R2 = 0.56, p=0.003) and Nf1+/- mice (n = 18; R2 = 0.23, p=0.045). (C) The
freezing acquisition rate (left; unpaired t-test; t29 = 2.08, p=0.046) and average freezing during trials 8–15 (middle; t29 = 4.79, p<0.001) were decreased
in Nf1+/- mice due to increased latency to freeze (right; t29 = 2.90, p=0.007). (D) Averaged dLight1.2 traces showing responses to CS (10 s, 3 kHz tone
with house light illumination) presentation and US (1 s, 0.4 mA shock) delivery. (E) Heatmaps showing trial-by-trial changes in dLight1.2 signal in
response to the CS (left). Nf1+/- mice (n = 12) displayed increased CS responses across trials (middle; two-way repeated measures ANOVA; F14,280 =
1.662, pgenotype x trial = 0.06; F14,280 = 9.30, ptrial <0.001; F1,20 = 4.37, pgenotype = 0.049) and when traces were averaged (right; unpaired t-test; t20 = 2.324,
p=0.03) compared to Nf1+/+ mice (n = 10). (F) Correlation matrix showing trial-by-trial correlation strength between behavioral measures and CS peak
response. (G) In Nf1+/- mice, there were significant correlations between the CS peak in trial one and the freezing acquisition rate (R2 = 0.40, p=0.03),
time spent freezing (R2 = 0.41, p=0.02), and the latency to freeze (R2 = 0.34, p=0.046). (H) Heatmaps showing trial-by-trial changes in dLight1.2 signal in
response to US delivery (left). Nf1+/- mice (n = 12) exhibited increased average peak responses (right) to US onset (t20 = 2.50, q = 0.04) and decreased
integrated post-US rebound (area under the curve or AUC; t20 = 2.85, q = 0.03) compared to Nf1
+/+ mice (n = 10). (I) Correlation matrices displaying
strength of US feature peak-behavior correlations during trial one and across trials. (J) There were significant correlations between the US anti-peak
magnitude in trial one and freezing (R2 = 0.58, p=0.01) or the latency to freeze (R2 = 0.46, p=0.03) in Nf1+/+ mice and the integrated post-US rebound
across all trials and the latency to freeze (R2 = 0.45, p=0.02) in Nf1+/- mice. *denotes p<0.05. Multiple t-tests were corrected with the two-stage linear
step-up procedure of Benjamini, Krieger, and Yekutieli with a false discovery rate of 5%. Data presented as mean ± SEM.
DOI: https://doi.org/10.7554/eLife.48983.017
The following figure supplement is available for figure 5:
Figure supplement 1. Additional data: Cued fear conditioning.
DOI: https://doi.org/10.7554/eLife.48983.018
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Figure 5H, Figure 5—figure supplement 1). US
anti-peak and post-US rebound peak responses
were equivalent between genotypes across trials
(Figure 5H, Figure 5—figure supplement 1). In
Nf1+/+ mice, the magnitude of the US anti-peak
during trial one was negatively correlated with
freezing and positively correlated with latency to
freeze (Figure 5I–J, Supplementary file 2). Addi-
tionally, the magnitude of the integrated post-US
rebound was negatively correlated with the
latency to freeze in Nf1+/- mice (Figure 5I–J,
Supplementary file 2). These findings demon-
strate that Nf1+/- mice exhibit altered patterns of
dopaminergic neurotransmission in response to
both shock-predictive cues and shock delivery,
which correlated with behavioral responses dur-
ing the task. Larger dopaminergic responses to the onset of the CS in the first trial was associated
with longer latencies to freeze and shorter freezing durations in Nf1+/- mice, while more negative
dopamine responses to shock delivery during trial one was predictive of shorter latencies to freeze
and longer freezing durations in Nf1+/+ mice.
Dopaminergic and behavioral responses to salient visual stimuli
In order to investigate the etiology of the dopaminergic response to the CS, we measured dLight1.2
responses to either a 10 s overhead light or a 3 kHz tone (inter-trial interval: 75–90 s) randomly pre-
sented during a 20-trial session. Both genotypes exhibited robust dopamine transients at the onset
of the overhead light stimulus that returned to baseline within 1–2 s (Figure 6A) and decremented
across trials (Figure 6—figure supplement 1). In both Nf1+/+ mice and Nf1+/- mice, 60 dB, 3 kHz
auditory tone evoked dopamine transients at stimulus onset (Figure 6B) that were comparatively
smaller than light responses (Figure 6C) and non-trial-dependent (Figure 6—figure supplement 1).
Nf1+/- mice exhibited larger responses to light but not tone onset (Figure 6C), which was confirmed
when traces were analyzed as DF/F rather than z-score (Figure 6—figure supplement 1). These find-
ings raise the possibility that phenotypic differences in dopaminergic CS responses are driven by
reactions to an overhead visual stimulus. In order to investigate if the overhead light affected perfor-
mance during cued fear conditioning, we performed the assay using a tone-only CS (3 kHz tone).
During the last five trials, tone-only trials were interleaved with trials in which the house light was
added to the CS (trials 11, 13, 15). We found that the development of cued freezing in Nf1+/- mice
was equivalent to Nf1+/+ littermates across the first ten trials (Figure 6D). Addition of the overhead
light stimulus to the CS was sufficient to perturb the expression of freezing in Nf1+/- but not Nf1+/+
mice by increasing the latency to freeze (Figure 6E, Video 3). Thus, deficits in cued fear conditioning
in Nf1+/- mice are reversible, visual stimulus-
dependent, and independent of learning.
Dopaminergic neurons, in addition to their
role in processing rewarding or aversive out-
comes, respond to salient alerting signals to
modulate attentional orientation and promote
appropriate motivated responses (Bromberg-
Martin et al., 2010; Schultz and Romo, 1990).
Because enhanced dopaminergic responses to an
overhead light may reflect increased motivational
salience of an alerting visual stimulus
(Thompson et al., 2010), we performed a loom-
ing stimulus assay in Nf1+/+ and Nf1+/- mice. Dur-
ing this test, subjects are exposed to an
expanding overhead disc designed to mimic
predator approach that rapidly promotes escape
and/or freezing behaviors in rodents (Yilmaz and
Video 2. Behavioral response of Nf1+/+ mouse to CS
presentation during fear conditioning.
DOI: https://doi.org/10.7554/eLife.48983.020
Video 3. Behavioral response of Nf1+/- mouse to CS
presentation during tone-only and interleaved light
trials.
DOI: https://doi.org/10.7554/eLife.48983.025
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Figure 6. Dopaminergic and behavioral responses to salient visual stimuli. (A) Average (left) and trial-by-trial (right) fluorescent dopamine response to a
10 s overhead light stimulus. (B) Average (left) and trial-by-trial (right) fluorescent dopamine response to a 10 s auditory stimulus (5 kHz tone). (C) Nf1+/-
mice had greater peak responses to light (p<0.001) but not tone onset (p>0.99) compared to Nf1+/+ mice (n+/+ = 10, n+/- = 10; two-way ANOVA with
Bonferroni post hoc tests; F1,36 = 7.27, pgenotype x condition = 0.01; F1,36 = 15.48, pgenotype <0.001). In both genotypes, responses to light were greater
than responses to tone (F1,36 = 71.02, pstimulus <0.001; p+/+ = 0.002, p+/- < 0.001). (D) No difference in cued fear conditioning was observed when a
tone-only CS was used (n+/+ = 9, n+/- = 10; two-way repeated measures ANOVA; F9,153 = 0.26, pgenotype x trial = 0.98). (E) Nf1
+/- mice exhibited increased
freezing (left) and decreased latency to freeze (right) in tone-only CS trials (n = 10) compared to light and tone (n = 18; unpaired t-test; freezing:
t26 = 3.75, p<0.001; latency: t26 = 3.75, p<0.00) or interleaved light trials (n = 10; paired t-test; freezing: t9 = 5.30, p<0.001; latency: t9 = 3.48, p=0.007).
No differences in freezing or latency to freeze was observed between tone-only CS trials (n = 9) and light and tone (n = 13; unpaired t-test; freezing:
t20 = 1.66, p=0.11; latency: t20 = 0.81, p=0.43) or interleaved light trials (n = 10; paired t-test; freezing: t8 = 0.42, p=0.69; latency: t8 = 1.49, p=0.19) in
Nf1+/+ mice. (F) Nf1+/+ (n = 17) and Nf1+/- mice (n = 23) had similar reaction times to a looming stimulus (left; t38 = 0.79, p=0.43), yet Nf1
+/+ mice were
more likely to escape to the shelter after stimulus presentation (left) and exhibited shorter latency to the first freezing episode after looming onset than
Nf1+/- mice (t38 = 3.24, p=0.003). (G) Optogenetic stimulation of the ventral superior colliculus (vSC) produced time-locked dopamine release in the
LNAc (n = 3 mice; average trace, left; trial-by-trial response, right). (H) Representative confocal image showing tyrosine hydroxylase (TH)-positive
dopaminergic and Th-Off-NpHR-eYFP neurons in the VTA (scale: 50 mm). (I) In the absence of photoinhibition, VTATh-Off-NpHR-eYFP Nf1+/- mice (n = 12)
were more likely to escape to the shelter (left) and had shorter latency to the first freezing episode (right; unpaired t-test; t22 = 2.36, p=0.03) compared
with VTATh-Off-mCherry Nf1+/+ mice (n = 12). Optogenetic inhibition of VTAnon-Th neurons with 532 nm light (5 mW, 30 Hz, 20 ms pulse width) decreased
the probability of escape to the shelter (left) and increased the latency to the first freezing episode (right; paired t-test; t11 = 3.82, p=0.003) in VTA
Th-Off-
NpHR-eYFP Nf1+/- mice to levels that were similar to VTATh-Off-mCherry Nf1+/+ mice (unpaired t-test; Nf1+/- Laser On vs Nf1+/+ Laser Off: t22 = 0.98, p=0.34;
Nf1+/- Laser On vs Nf1+/+ Laser On: t22 = 1.09, p=0.29). No difference was observed in VTA
Th-Off-mCherry Nf1+/+ mice between stimulation conditions (paired
t-test; t11 = 0.02, p=0.99). *denotes p<0.05. # denotes p<0.05 vs light stimulus (panel C). Data presented as mean ± SEM.
DOI: https://doi.org/10.7554/eLife.48983.021
The following figure supplements are available for figure 6:
Figure 6 continued on next page
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Meister, 2013). In response to the onset of the looming stimulus, both genotypes exhibited similar
sub-second reaction times (Figure 6—figure supplement 2). Compared to Nf1+/+ littermates, Nf1+/-
mice were more likely to escape to the shelter at stimulus onset and exhibited shorter latencies to
the first freezing episode (Figure 6F). In both groups, freezing latency was not dependent on freez-
ing location (Figure 6—figure supplement 2). No differences in the length of the first freezing epi-
sode or total freezing during the first minute after looming were observed between genotypes,
although freezing was dependent on escape location: mice that escaped to the shelter exhibited
shorter freezing durations than those in the open field (Figure 6—figure supplement 2).
Recently, it has been shown that flight-to-shelter responses to looming stimuli are mediated by
VTA GABAergic neurons and driven by excitatory projections from the ventral superior colliculus
(vSC) (Zhou et al., 2019). This projection innervates both dopaminergic and GABAergic neurons in
the VTA (Pre´vost-Solie´ et al., 2019; Zhou et al., 2019) and additionally regulates orientation during
social interaction (Pre´vost-Solie´ et al., 2019). In order to determine if the vSC can induce dopami-
nergic neurotransmission in a manner similar to overhead light exposure, we stereotaxically injected
an AAV vector (AAV5-hSyn-ChR2(H134R)-eYFP) into the vSC to express the light-gated ion channel
channelrhodopsin-2 (ChR2) in neurons, followed by implantation of an optical fiber for 473 nm light
delivery in C57Bl/6N mice. A photometry fiber was also implanted in the ipsilateral LNAc for simulta-
neous dLight1.2 monitoring during vSC photostimulation. Similar to overhead light exposure, two
seconds of vSC optogenetic stimulation (5 mW, 20 Hz, 5 ms pulse width) produced time-locked,
short latency dopamine release in the LNAc at stimulus onset that subsequently decayed to baseline
(Figure 6G, Figure 6—figure supplement 3). In early trials, the signal decayed to sub-baseline, neg-
ative values. Discontinuation of the laser was associated with a robust dopaminergic rebound. Dur-
ing testing, we also observed that vSC ChR2 activation evoked vigorous escape behavior in the
absence of a threatening stimulus (Video 4), as has been observed following photostimulation of
vSC-to-VTA projections (Zhou et al., 2019). These findings indicate that the SC, a visually responsive
region involved in innate responses to salient visual stimuli (Ito and Feldheim, 2018), can induce
rapid dopamine release in the LNAc that is qualitatively similar to overhead light exposure.
Optogenetic inhibition of non-dopaminergic neurons in the VTA of
Nf1+/- mice during looming stimulus presentation
Optogenetic inhibition of VTA GABAergic neurons or vSC projections in the VTA is sufficient to sup-
press looming stimulus responses in mice (Zhou et al., 2019). Given that Nf1 heterozygosity is asso-
ciated with excitation-inhibition imbalance in the VTA, we hypothesized that suppression of
inhibitory neurotransmission during looming stimulus presentation would normalize behavioral
responses in Nf1+/- mice. To test this hypothesis, we used an intersectional strategy to target
GABAergic neurons in the VTA for optogenetic silencing with the light-gated chloride pump halor-
hodopsin (NpHR) during behavior. We co-injected an AAV vector to express Cre recombinase under
control of the Th promoter in dopaminergic neurons (AAV9-Th-PI-Cre-SV40) with either a Cre-Off
NpHR (AAV-DJ-Ef1a-DO-eNpHR3.0-eYFP, Nf1+/- mice) or mCherry (AAV-DJ-Ef1a-DO-mCherry,
Nf1+/+ mice) vector bilaterally into the VTA (Saunders et al., 2012), followed by implantation of 300
mm optical fibers for light delivery. Because the mCherry or NpHR transgenes were double-floxed
with an open reading frame (DO), they would be inactivated in the presence of Cre but express nor-
mally in non-dopaminergic neurons (Figure 6H). Given that ~90% of non-dopaminergic neurons are
GABAergic in the VTA (Morales and Root, 2014; Pignatelli and Bonci, 2015), we reasoned that our
approach would provide efficient optogenetic control of inhibitory neurotransmission in this region.
Post hoc analysis revealed that only 14.7 ± 0.01% of NpHR-positive cells in the VTA expressed
Figure 6 continued
Figure supplement 1. Additional data: dLight1.2 responses to auditory and visual stimuli.
DOI: https://doi.org/10.7554/eLife.48983.022
Figure supplement 2. Additional data: Looming stimulus assay.
DOI: https://doi.org/10.7554/eLife.48983.023
Figure supplement 3. Additional data: Optogenetic control of the vSC and VTAnon-Th neurons.
DOI: https://doi.org/10.7554/eLife.48983.024
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tyrosine hydroxylase (Figure 6H, Figure 6—figure supplement 3), indicating successful targeting of
VTAnon-Th neurons in Nf1+/- and Nf1+/+ mice.
In the absence of optogenetic inhibition, optical patch cable-tethered VTATh-Off-NpHR-eYFP Nf1+/-
mice were more likely to escape to the available shelter in response to looming stimulus presenta-
tion and exhibited shorter latency to the first freezing episode when compared to VTATh-Off-mCherry
Nf1+/+ mice (Figure 6I). Delivery of 532 nm light (5 mW, 30 Hz, 20 ms pulse width) to the VTA during
looming stimulus presentation had no effect on VTATh-Off-mCherry Nf1+/+ mice but decreased the per-
centage of VTATh-Off-NpHR-eYFP Nf1+/- mice that escaped to the shelter to a level (33%) that was simi-
lar to Nf1+/+ mice (41%) and VTATh-Off-mCherry Nf1+/+ mice (42%) (Figure 6F–I; Video 5). This shift in
escape location coincided with an increase in the latency to the first freezing episode in VTATh-Off-
NpHR-eYFP Nf1+/- mice that was not significantly different from VTATh-Off-mCherry Nf1+/+ mice
(Figure 6I). Thus, optogenetic inhibition of VTAnon-Th neurons normalizes looming stimulus responses
in Nf1+/- mice and supports a role for VTA GABAergic neurons in the expression of visual stimulus
response phenotypes caused by Nf1 haploinsufficiency.
Discussion
Developmental perturbations in mesencephalic dopaminergic circuits have been hypothesized to
contribute to neurocognitive symptoms in NF1, yet their activity has never been directly investigated
in vivo. Here we leveraged the novel dopamine sensor dLight1.2 to assay mesoaccumbal dopamine
dynamics in awake, behaving NF1 model mice and observed that the frequency of spontaneous fluo-
rescent dopaminergic transients was lower in Nf1+/- mice. Using patch clamp electrophysiology, we
showed that Nf1+/- dopaminergic neurons are less excitable and have lower spontaneous firing rates
ex vivo due to increased GABAergic tone. Pharmacological or optogenetic inhibition of VTA
GABAergic neurons rescued spontaneous dopaminergic and behavioral phenotypes, respectively.
Given these findings, it is likely that increased tonic inhibition of Nf1+/- dopaminergic neurons
reduces basal activity, whereas smaller soma volume acts as a compensatory mechanism to increase
excitability during disinhibition. This would serve to facilitate bursting in response to a strong stimu-
lus and maintain dLight1.2 transient amplitude, although future studies monitoring dopaminergic
neuron activity with single cell resolution will be required to fully parse this hypothesis. Excitation/
inhibition imbalance is present in the amygdala (Molosh et al., 2014; Repunte-Canonigo et al.,
2015), striatum (Shilyansky et al., 2010), and medial prefrontal cortex (mPFC) (Gonc¸alves et al.,
2017; Shilyansky et al., 2010) of Nf1+/- mice and likely contributes to deficits in working memory,
contextual fear conditioning, and social memory (Cui et al., 2008; Molosh et al., 2014;
Shilyansky et al., 2010). Subthreshold doses of picrotoxin (0.01 mg/kg) (Cui et al., 2008) or
L-DOPA (Wozniak et al., 2013) improve cognitive performance of NF1 model mice, emphasizing
the therapeutic potential of interventions that modulate mesolimbic dopaminergic circuit function.
Although Nf1+/- dopaminergic neurons exhibit decreased soma size, we failed to detect changes
in VTA or NAc TH immunofluorescence, as well as NAc monoamine content. This is in contrast with
the optic glioma (OPG) mouse model of NF1 that has reduced tyrosine hydroxylase expression in
the VTA (Brown et al., 2012; Diggs-Andrews et al., 2013) and lower TH, dopamine, and phosphor-
ylated DARPP-32 (dopamine and cAMP-regulated phosphoprotein-32) in terminal fields
(Brown et al., 2010a; Diggs-Andrews et al., 2013; Anastasaki et al., 2015). Neurite outgrowth
and growth cone areas are decreased in cultured OPG dopaminergic neurons (Diggs-
Andrews et al., 2013), yet we did not observe changes in neurite morphology in Th-VAST-labeled
Nf1+/- neurons relative to Nf1+/+ littermates. Incongruence between mouse models may be due to
relative differences in neurofibromin expression. Nf1+/- mice on a pure C57Bl/6 background have
higher tissue neurofibromin levels compared to OPG mice, and neurofibromin dose-dependently
regulates TH and cellular dopamine production in cultured mouse neurons and neural progenitor
cells differentiated from patient-derived induced pluripotent stem cells (Anastasaki et al., 2015).
While the etiology of reduced soma volumes is unknown, cAMP deficiency influences the morphol-
ogy of Nf1+/- and OPG neurons in vitro (Brown et al., 2012; Diggs-Andrews et al., 2013). Perturba-
tions in this pathway thus represents a mechanism of interest in future efforts to characterize
mesencephalic development in the context of NF1.
We also observed that Nf1+/- mice exhibit more robust dopaminergic responses to an overhead
visual light stimulus, which was correlated with delayed freezing in a cued fear conditioning task.
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These findings are not indicative of an inability to form cue-outcome associations, since Nf1+/- mice
performed similarly to Nf1+/+ littermates when conditioning was carried out in the absence of the
light stimulus. NAc dopaminergic neurotransmission is necessary for the acquisition and expression
of learned fear responses (Fadok et al., 2010; Fadok et al., 2009), so enhanced CS responses
would be expected to promote not attenuate conditioned fear. More likely, exaggerated dopami-
nergic responses to light presentation reflect increased stimulus salience, as overhead light stimuli
are aversive in mice (Thompson et al., 2010), unexpected salient visual cues promote dopaminergic
firing (Bromberg-Martin et al., 2010), and Nf1+/- mice had more robust behavioral responses to a
looming stimulus. Work by Schultz and colleagues suggests that alerting dopamine signals, unlike
reward responses, enable orientation and stimulus investigation (Schultz, 2010). As such, increased
visual cue salience in Nf1+/- mice may have increased freezing latency during fear conditioning by
provoking an investigative locomotor response in the absence of an obvious escape location.
Because the looming disc is designed to simulate a predatory environmental cue, it has a greater
negative valance; in this case, increased stimulus salience would promote flight-to-shelter responses
and reduce the latency to the first freezing episode. Thus, bidirectional effects of Nf1 heterozygosity
on freezing latency could be consistent with a single phenotypic process and depend on visual stim-
ulus intensity and the ability to escape.
Adult and adolescent human subjects with NF1 exhibit visual processing deficits (Hyman et al.,
2005), although visual cortical areas have sparse, if any, direct connections to VTA dopaminergic
neurons (Watabe-Uchida et al., 2012). Short latency dopaminergic responses to visual stimuli are
likely driven by afferents from the superior colliculus (SC) (Redgrave et al., 2010), which receives
direct input from retinal ganglion cells (Dhande and Huberman, 2014), responds to looming stimuli
(Zhao et al., 2014), and evokes firing of both VTA GABAergic and dopaminergic neurons in vivo
while enhancing flight-to-shelter responses (Pre´vost-Solie´ et al., 2019; Zhou et al., 2019). Because
the dopaminergic response to optogenetic vSC stimulation occurred at stimulus onset, quickly atten-
uated, and was followed by a post-stimulation rebound, it is likely that excitatory vSC-to-VTA projec-
tions excite and subsequently suppress dopaminergic outflow via feed-forward inhibition, producing
rebound disinhibition at stimulus offset. While the initial dopaminergic peak may serve as a salience
signal, flight-to-shelter responses appear to be mediated by VTA GABA neurons (Zhou et al.,
2019). In this case, increased vSC-to-VTA excitatory drive in Nf1+/- mice would be predicted to
enhance LNAc dopamine release at stimulus onset, while subsequently driving signal termination
and escape responses via GABAergic neurons. Thus, the role of tectal inputs to the VTA in moderat-
ing visual stimulus sensitivity in NF1 mouse models represents a promising focus for future efforts to
parse disease symptomatology and may provide new insights into visual processing in patient
populations.
Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Antibody Anti-tyrosine hydroxylase
(Rabbit
polyclonal)
EMD Millipore Cat#: AB152
RRID:AB_390204
IHC (1:1000)
Antibody Anti-tyrosine hydroxylase
(mouse
monoclonal)
ImmunoStar Cat#: 22941
RRID:AB_572268
IHC (1:1000)
Antibody Anti-GFP
(mouse
polyclonal)
Aves Cat#: GFP-1020
RRID:AB_10000240
IHC (1:1000)
Continued on next page
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Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Antibody Alexa Fluor
488-conjugated
donkey
anti-chicken
IgY
F(ab’)two
fragment
Jackson
Immuno
Research
Cat#: 703-546-155
RRID:
AB_2340376
IHC (1:1000)
Antibody Alexa
Fluor 647-
conjugated
donkey
anti-mouse
IgG Fab
fragment
Jackson Immuno
Research
Cat#: 711-607-003
RRID:
AB_2340626
IHC (1:1000)
Recombinant
DNA
reagent
pAAV-hSyn-
dLight1.2
Addgene Plasmid#: 111068
RRID:
Addgene_111068
Gift on Lin Tian;
produced by UC
Davis Vector Core
Recombinant
DNA
reagent
pAAV-hSyn-hChR2(H134R)-
EYFP
Addgene Plasmid#: 26973
RRID
:Addgene_26973
Gift of Karl
Deisseroth;
produced
by UNC Vector Core
Recombinant
DNA
reagent
AAV9-Th-PI-
Cre-SV40
Addgene Plasmid#: 107788
RRID:
Addgene_107788
Addgene viral
prep#:
107788-AAV9;
gift of
James M. Wilson
Recombinant
DNA
reagent
pAAV-DJ-
Ef1a-DO-
eNpHR3.0-
eYFP-WPRE-pA
Addgene Plasmid#: 37087
RRID:
Addgene_37087
Gift of Bernardo
Sabatini
Recombinant
DNA
reagent
pAAV-DJ-
Ef1a-DO-
mCherry-
WPRE-pA
Addgene Plasmid#: 37119
RRID:
Addgene_37119
Gift of Bernardo
Sabatini
Recombinant
DNA
reagent
pAAV-ihSyn1-tTA-WPRE Addgene Plasmid#: 99120
RRID:
Addgene_99120
Recombinant
DNA
reagent
pAAV-Th-t
TA-WPRE
Addgene Plasmid#: 133268
RRID:
Addgene_133268
Recombinant
DNA
reagent
pAAV-TRE-
mRuby-WPRE
Addgene Plasmid#: 99114
RRID:
Addgene_99114
Recombinant
DNA
reagent
pAAV-TRE-mNeonGreen-
WPRE
(Chan et al., 2017)
Recombinant
DNA
reagent
pAAV-TRE-mTurquoise-
WPRE
Addgene Plasmid#: 99113
RRID:
Addgene_99113
Recombinant
DNA
reagent
pAAV-Th-
GFP-WPRE
Addgene Plasmid#:
99128
RRID:
Addgene_99128
Recombinant
DNA
reagent
pUCmini-
iCAP-PHP.eB
Addgene Plasmid#: 103005
RRID:
Addgene_103005
Recombinant
DNA
reagent
pAAV-DJ-Rep-Cap Cell Biolabs, Inc Cat#: VPK-420-DK
Continued on next page
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Continued
Reagent type
(species) or resource Designation Source or reference Identifiers
Additional
information
Software,
Algorithm
Matlab Mathworks, Inc RRID:SCR_001622
Software,
Algorithm
GraphPad Prism 7 GraphPad
Software, Inc
RRID:SCR_002798
Software,
Algorithm
ABET II
Software for
Operant Control
Lafayette
Instrument
Company
Model 89501
Software,
Algorithm
Fiber
Photometry
Trace Processing
Gradinaru Lab FP_Session_
Processing_2 .m
https://github.com/
GradinaruLab/d
Light1/blob
/master/FP_
Session_Processing2.m
Other ProLong
Diamond
Antifade
Mountant
ThermoFisher
Scientific
Cat#: P36965
Other Refractive
Index
Matching
Solution
(Yang et al., 2014) Refractive
Index = 1.46;
protocol
available in
Treweek et al. (2015)
Other Mono
Fiber-Optic
Cannula
Doric Lenses,
Inc
Cat#:
MFC_400/430–0.48_
5 mm_ZF1.25_FLT
OD: 400 mm,
Length: 5 mm
Other Mono
Fiber-Optic
Cannula
Doric Lenses,
Inc
Cat#:
MFC_300/330–0.48_
3 mm_ZF1.25_FLT
OD: 300 mm,
Length: 3 mm
Other Mono
Fiber-Optic
Cannula
Doric Lenses,
Inc
Cat#:
MFC_300/330–0.48_
5 mm_ZF1.25_FLT
OD: 300 mm,
Length: 5 mm
Other Mono
Fiber-Optic
Patch Cable
Doric Lenses,
Inc
Cat#: MFP_400/430
/LWMJ-0.48_
2 m_FC-
ZF1.25, Doric
Lenses Inc
OD: 400 mm,
Length: 2 m
Other Mono
Fiber-Optic
Patch Cable
Doric Lenses,
Inc
Cat#: MFP_300/
330
/LWMJ-0.48
_1 m_FC-ZF1.25,
Doric
Lenses Inc
OD: 300 mm,
Length: 1 m
Experimental animals
Experimental subjects were 8–12 week old 129T2/SvEmsJ::C57Bl/6NTac Nf1+/+ and Nf1+/- male and
female mice that were generated via the F1 cross of 129T2/SvEmsJ male mice (the Jackson Labora-
tory Stock No: 002065) and C57Bl/6NTac Nf1+/- female mice (generous gift of Dr. Alcino Silva,
UCLA). Animals were group housed (3–4 per group) throughout the duration of the experiment in a
vivarium on a 12 hr light/dark cycle (lights off at 0600 hr, lights on at 1800 hr) with ad libitum access
to food and water. Fluid restricted animals were singly housed, and their water access was limited to
1.5 mL/day. These mice were weighed daily and were returned to ad libitum water access if their
weight decline was >10% of their pre-restriction weight. Animal husbandry and experimental proce-
dures involving animal subjects were conducted in compliance with the Guide for the Care and Use
of Laboratory Animals of the National Institutes of Health and approved by the Institutional Animal
Care and Use Committee (IACUC) and by the Office of Laboratory Animal Resources at California
Institute of Technology under IACUC protocol 1730. Mice were only excluded from behavioral stud-
ies if they could not complete the entire experiment due to health concerns, if there was no dynamic
photometry signal 3 weeks after surgery, or if the location of the photometry fiber tip was
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histologically determined to be outside the LNAc (1 mouse). All behavioral experiments were per-
formed in at least two cohorts to minimize batch effects. All experiments were performed and ana-
lyzed blinded to genotype using automated, batched data analysis scripts/software wherever
possible to eliminate experimenter bias. Littermate controls were used throughout the study.
Patch-clamp electrophysiology
Whole-cell patch-clamp recordings were performed as previously described (Cho et al., 2017) in
acute brain slices. Acute 250 mm-thick horizontal slices that contained the lateral VTA were prepared
on a vibratome (VT-1200, Leica Biosystems) from 8 to 12 week Nf1+/+ and Nf1+/- mice that had been
transcardially perfused with an ice-cold NMDG cutting solution (Ting et al., 2014) saturated with
95% O2/5% CO2. Slices were recovered at 32˚C in NMDG cutting solution for ten minutes prior to
transfer to HEPES recovery artificial cerebrospinal fluid (ACSF) (Ting et al., 2014) for an additional
30 min of recovery. During recording, slices were continuously perfused (2.0–3.0 mL/min) with 32˚C,
95% O2/5% CO2 -saturated recording ACSF that contained (mM): 125 NaCl, 2.5 KCl, 1.2 NaH2PO4,
1.2 MgCl2, 2.4 CaCl2, 26 NaHCO3, and 11 glucose. The medial terminal nucleus of the accessory
optic track (MT) was used as a visual landmark to delineate the most lateral region of the VTA.
Whole-cell patch clamp recordings were obtained using 3–6 MW patch pipettes fabricated from
borosilicate capillary glass tubing (World Precision Instruments) and backfilled with a potassium glu-
conate internal solution that contained (mM): 135 K gluconate, 5 KCl, 5 EGTA, 0.5 CaCl2, 10 HEPES,
2 Mg-ATP, and 0.1 GTP. A high-chloride internal solution was used to measure IPSCs and contained
(mM): 128 KCl, 20 NaCl, 1 MgCl2 1 EGTA, 0.3 CaCl2, 10 HEPES, 2 Mg-ATP, and 0.3 GTP. Signals
were amplified and digitized using a MultiClamp 700B amplifier (Molecular Devices, LLC) and Digi-
data 1440 analog-to-digital converter (Molecular Devices, LLC). Series resistance (Rs) was monitored
throughout recording, and data were discarded if the uncompensated Rs exceeded 30 MW or the
holding current at  70 mV was more negative than  200 pA. Rheobase currents were determined
via the injection of a 500 pA ramp current over 500 ms from  60 mV in current clamp mode. Ih cur-
rents were measured during seven 2 s,  10 mV hyperpolarizing voltage steps from  60 mV in volt-
age clamp in the presence of 20 mM bicuculline methiodide and 3 mM kynurenic acid + /- 20 mM
forskolin. Spontaneous firing was measured over twenty seconds of gap free recording in I = 0
mode. Spontaneous IPSCs and EPSCs were measured at  70 mV in voltage clamp. IPSCs were
recorded in the presence of 3 mM kynurenic acid. Electrophysiological data were sampled at 10 kHz
and filtered at 2 kHz with Clampex 10.4 and analyzed in Clampfit 10.7 (Molecular Devices, LLC).
Surgical procedures
Stereotaxic viral vector injections were performed in mice anesthetized with isoflurane (1–3% in 95%
O2/5% CO2 provided via nose cone at 1 L/min) as previously described (Cho et al., 2017). Following
anesthesia, preparation and sterilization of the scalp, and exposure of the skull surface, a craniotomy
hole was drilled over the LNAc (antero-posterior: 1.2 mm, medio-lateral: 1.6 mm relative to Bregma).
800 nL of the AAV9-hSyn-dLight1.2 vector (titer:~4  1012 viral genomes/mL, produced at the UC
Davis Vision Center Vector Design and Packaging Core facility; Addgene # 111068) was delivered
into the LNAc (antero-posterior: 1.2 mm, medio-lateral: 1.6 mm, dorso-ventral:  4.2 mm relative to
Bregma) using a blunt 33-gauge microinjection needle within a 10 mL microsyringe (NanoFil, World
Precision Instruments), a WPI microsyringe pump (UMP3, World Precision Instruments), and pump
controller (Micro4, World Precision Instruments) over 10 min. Following viral injection, a 5 mm long,
400 mm outer diameter mono fiber-optic cannula (MFC_400/430–0.48_5 mm_ZF1.25_FLT, Doric
Lenses Inc) was lowered to the same stereotaxic coordinates and affixed to the skull surface with C
and B Metabond (Parkel Inc) and dental cement. For optogenetic stimulation of the SC during
dLight1.2 recordings, mice received a second stereotaxic injection of AAV5-hSyn-ChR2(H134R)-eYFP
(UNC Vector Core) in the SC (antero-posterior:  4.0 mm, medio-lateral: 0.5 mm, dorso-ventral:  1.5
mm relative to Bregma), followed by implantation of a 3 mm long, 300 mm mono fiber-optic cannula
(MFC_300/330–0.48_3 mm_ZF1.25_FLT, Doric Lenses Inc; antero-posterior:  4.0 mm, medio-lateral:
0.5 mm, dorso-ventral:  1.3 mm relative to Bregma). For optogenetic inhibition of VTAnon-Th neu-
rons, 500 nL of a 1:4 mixture of AAV9-Th-PI-Cre-SV40 (gift of James M. Wilson, Addgene viral prep
# 107788-AAV9) and AAV-DJ-Ef1a-DO-eNpHR3.0-eYFP-WPRE-pA (gift of Bernardo Sabatini, Addg-
ene # 37087) or AAV-DJ-Ef1a-DO-mCherry-WPRE-pA (gift of Bernardo Sabatini, Addgene # 37119)
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was injected bilaterally into the VTA (antero-posterior:  3.3 mm, medio-lateral: ± 0.5 mm, dorso-
ventral:  4.2 mm relative to Bregma), followed by implantation of 5 mm long, 300 mm mono fiber-
optic cannulae (MFC_300/330–0.48_5 mm_ZF1.25_FLT; antero-posterior:  3.3 mm, medio-
lateral: ± 1.84 mm, dorso-ventral:  3.59 mm relative to Bregma) at angle of twenty degrees. Mice
were given 1 mg/kg buprenorphine SR and 5 mg/kg ketoprofen s.c. intraoperatively and received 30
mg/kg ibuprofen p.o. in their home cage water for five days post-operatively for pain. Mice were
allowed a minimum of 14 days for surgical recovery prior to participation in behavioral studies.
Systemic AAV vector production and administration
In order to create Th-VAST, a PCR fragment containing the 2.5 kb rat tyrosine hydroxylase promoter
(Oh et al., 2009) was subcloned into pAAV-ihSyn1-tTA-WPRE (Addgene #99120), replacing the
ihSyn promoter through AflII and MluI restriction digest to create pAAV-Th-tTA-WPRE. pAAV-TRE-
mRuby-WPRE (Addgene # 99114), pAAV-TRE-mNeonGreen-WPRE, pAAV-TRE-mTurquoise-WPRE
(Addgene # 99113), pAAV-Th-GFP-WPRE (Addgene # 99128), pAAV-Ef1a-DO-mCherry-WPRE-pA
(Addgene # 37119), and pAAV-Ef1a-DO-NpHR3.0-eYFP-WPRE-pA (Addgene # 37087) constructs
were used as previously described (Chan et al., 2017; Saunders et al., 2012). Virus production was
performed using a published protocol (Challis et al., 2019). In brief, HEK293T cells were triple trans-
fected using polyethylenimine (PEI) to deliver viral pUCmini-iCAP-PHP.eB (Addgene #103005) or
pAAV-DJ-Rep-Cap (VPK-420-DK, Cell Biolabs, Inc), pHelper, and transgene plasmids. Viral particles
were harvested from the media and cell pellet and purified over 15%, 25%, 40% and 60% iodixanol
(OptiPrep, STEMCELL Technologies, Inc) step gradients. Viruses were concentrated using Amicon
Ultra centrifugal filters (Millipore Sigma), formulated in sterile phosphate buffered saline, and titered
with qPCR by measuring the number of DNase I–resistant viral genomes relative to a linearized
genome plasmid as a standard. Following viral production and titering, systemic AAV vectors were
administered via injection into the retro-orbital sinus during anesthesia with isoflurane (1–3% in 95%
O2/5% CO2 provided via nose cone at 1 L/min), followed by administration of 1–2 drops of 0.5%
proparacaine to the corneal surface (Challis et al., 2019). Note: we have observed some toxicity
with doses of AAV-PHP.eB-Th-tTA11011 vg/mouse when allowed to express >3 weeks; therefore,
we encourage users to perform dosing and time course studies when beginning experiments with
Th-VAST.
Fiber photometry
Fiber photometry was used to monitor fluorescent dopamine signals using a custom system as previ-
ously described (Cho et al., 2017; Patriarchi et al., 2018), which allowed for dLight1.2 excitation
and emission light to be delivered and collected via the same implanted optical fiber. Our system
employed a 490 nm LED (M490F1, Thorlabs, Inc; filtered with FF02-472/30-25, Semrock) for fluoro-
phore excitation and a 405 nm LED for isosbestic excitation (M405F1, Thorlabs Inc; filtered with
FF01-400/40-25, Semrock), which were modulated at 211 Hz and 531 Hz, respectively, controlled by
a real-time processor (RX8-2, Tucker David Technologies), and delivered to the implanted optical
fiber via a 0.48 NA, 400 mm diameter mono fiber optic patch cable (MFP_400/430/LWMJ-0.48_2
m_FC-ZF1.25, Doric Lenses Inc). The emission signal from isosbestic excitation, which has previously
been shown to be calcium independent for GCaMP sensors (Kim et al., 2016; Lerner et al., 2015),
was used as a reference signal to account for motion artifacts and photo-bleaching. Emitted light
was collected via the patch cable, collimated, filtered (MF525-39, Thorlabs), and detected by a
femto-Watt photoreceiver (Model 2151, Newport Co.) after passing through a focusing lens (62–
561, Edmunds Optics). Photoreceiver signals were demodulated into dLight1.2 and control (isosbes-
tic) signals, digitized (sampling rate: 382 Hz), and low-pass filtered at 25 Hz using a second-order
Butterworth filter with zero-phase distortion. A least-squares linear fit was applied for the 405 nm
signal to be aligned with the 490 nm signal. Then, the fitted 405 nm signal was subtracted from 490
nm channel, and then divided by the fitted 405 nm signal to calculate DF/F values. The code to per-
form this function is available at: https://github.com/GradinaruLab/dLight1/blob/master/FP_Session_
Processing2.m.
During behavioral experiments, the DF/F time-series trace was normalized using a robust z-score
( signal signal median
median absolute deviation
) to account for data variability across animals and sessions. When fiber photometry
was performed during behavioral testing, dLight1.2 signals were synchronized to the beginning of
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the behavioral session by delivery of TTL pulses
(via a TTL pulse generator; OTPG_4, Doric Lenses
Inc) to the photometry system.
Behavioral assays
Baseline dLight1.2 Measurements: Mice were
tethered to the photometry patch cable, placed
in a clean home cage within a sound attenuating
box, and allowed to habituate for 5 min (Lafay-
ette Instrument Company). Spontaneous
dLight1.2 signals were subsequently recorded for
5 min. This procedure was repeated at least three
times per mouse. During pre-treatment experi-
ments, morphine sulfate (5.0 mg/kg s.c.) or saline
(s.c.) was administered twenty minutes prior to
the onset of each session. Median fluorescence
was determined from the processed DF/F time-series trace using the median() function in Matlab;
peak analysis was performed on the normalized, z-scored trace using a two z-score threshold to min-
imize contamination by fluorescent noise. Dopamine transients were detected using the findpeaks()
function in Matlab, and outputs were averaged within each subject across trials.
Reward Consumption and Pavlovian Conditioning: During the twenty-minute sucrose consump-
tion assay, mice were given access to ten 50 mL sucrose (5% w/v) rewards delivered every 60 s (0.5
mL total) via a lick port in a mouse modular test chamber (Model 80015NS, Lafayette Instrument
Company) placed within a sound-attenuating box and controlled by ABET II software (Lafayette
Instrument Company). Sucrose consumption was characterized by measuring the timing and number
of licks at the lick spout, which was measured with an optical lickometer in the lick port. Lick bouts
were defined as licking events that exceeded five licks/second and were at least 3 s removed from a
previous lick bout. During the Pavlovian conditioning assay, mice were conditioned to associate the
presence of a 10-s conditioned stimulus (CS; illumination of the house-light and delivery of a 60 dB,
3 kHz tone) with delivery of the unconditioned stimulus (US; 50 mL 5% sucrose w/v; 1000 mL total
fluid delivery/session) 7 s after the onset of the CS. Each conditioning session consisted of twenty tri-
als with an inter-trial interval randomly drawn from a uniform distribution between 75 and 105 s. On
day 11, the sucrose US was omitted to determine dLight1.2 responses to reward omission (Day 11,
Trial 1). The number of licks during CS presentation were determined for each trial using ABET II.
Because US consumption often occurred during the inter-trial interval, the US timing was determined
by identifying the first lick bout after reward presentation during each trial.
Cued Fear Conditioning: During the cued fear conditioning task, a ten-second CS (60 dB, 3 kHz
tone and house light illumination) immediately preceded a 1 s, 0.4-mA foot shock delivered via the
grid floor of the conditioning chamber (Lafayette Instrument Company). The conditioning procedure
was completed during 15 consecutive trials with
an inter-trial interval randomly drawn from uni-
form distribution between 75 and 105 s. Mice
were videotaped during the assay under dim red
light conditions so that the amount of time freez-
ing (defined as the absence of any body move-
ment) and the latency to freeze during each trial
could be quantified post hoc by two blinded
reviewers.
Audiovisual Stimulus Exposure: Mice were
placed in a clean home cage in the sound attenu-
ating chamber placed underneath the speaker
and house light from the modular conditioning
chamber. During each trial, mice were randomly
presented with either a ten-second 60 dB, 3 kHz
tone or house light illumination, which had equal
probability of selection. Each session consisted of
Video 4. Behavioral response to optogenetic
stimulation of the superior colliculus.
DOI: https://doi.org/10.7554/eLife.48983.026
Video 5. Behavioral response to looming stimulus in
Nf1+/- mouse with or without optogenetic inhibition of
VTAnon-Th neurons.
DOI: https://doi.org/10.7554/eLife.48983.027
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twenty trials, and the inter-trial interval was randomly drawn from a uniform distribution between 75
and 105 s.
Social Interaction and Social Preference Assay: Test mice were placed in a clean cage and allowed
to freely interact with a juvenile, sex-matched, novel, conspecific probe mouse. Social interactions
were videotaped, and the onset of recording was synchronized with the photometry signal via deliv-
ery of TTL pulses. The onset of each social interaction was defined as the initiation of physical con-
tact between mice and was terminated when mice physically disengaged. The social preference
assay was performed in a 50 cm x 50 cm square, white acrylic arena that contained two identical,
wire mesh-enclosed social interaction vestibules placed in the center of opposite walls of the arena.
During each thirty-minute testing session, a juvenile, sex-matched, novel, conspecific probe mouse
was placed in one of the vestibules, and the position of the test mouse was tracked with an over-
head camera using EthoVision XT 10 (The Noldus Company). The location of the probe mouse was
alternated between trials.
Looming Stimulus Assay: The looming stimulus assay was performed as previously described
(Yilmaz and Meister, 2013). Mice were acclimated in an 87 cm x 47.5 cm x 30 cm (h) infrared-trans-
mitting black acrylic arena in the presence of a nest/shelter for at least five minutes. The overhead
looming stimulus was presented when the animal was in the center of the arena. The looming stimu-
lus covered 5 degrees of the animal’s visual field initially, expanded up to 50 degrees, and was pre-
sented five times separated by 1 s pauses on a gray background. For optogenetic manipulations,
the looming stimulus was presented as described above in an arena that was optimized for behav-
ioral testing in tethered mice that measured 50 cm x 35 cm x 30 cm (h). In order to accommodate
optical patch cables, the arena featured a rectangular opening adjacent to the overhead screen and
a triangular nest/shelter with a 2 cm slit at the apex. During testing, laser pulses (532 nm, 5 mW, 20
Hz, 5 ms pulse width) were delivered via the implanted optical fibers, which were coupled to optical
patch cables (MFP_300/330/LWMJ0.48_1 m_FC-ZF1.25, Doric Lenses Inc) connected to a 532 nm
laser (Changchun New Industries [CNI] Model with PSU-H-LED). Stimulation began 1.5 s prior to
looming onset and continued throughout the stimulus presentation. Mice were videotaped through-
out so that time to react to the disc, escape location, latency to the first freezing episode, duration
of the first freezing episode, and amount of time spent freezing during the first minute after expo-
sure could be quantified by a blinded reviewer.
Optogenetic Stimulation of the Superior Colliculus: Mono fiber-optic patch cables were con-
nected to implanted optical fibers for fiber photometry in the LNAc and optogenetic stimulation of
the ipsilateral vSC. The vSC patch cable was connected to a 473 nm laser (Changchun New Indus-
tries [CNI] Model with PSU-H-LED) and controlled by a Doric Lenses OTPG_4 pulse generator that
was triggered by the ABETII software. Mice were allowed to habituate in a clean home cage within
the Lafayette sound-attenuating chamber for 5 min prior to the start of the experiment. Following
habituation, dLight1.2 signals were recorded during twenty trials in which the vSC was stimulated
with 2 s of 20 Hz, 5 ms, 473 nm laser pulses. The inter-trial interval was randomly drawn from a uni-
form distribution between 75 and 105 s.
Histology
Free-floating brain sections were blocked for 1 hr in 10% normal donkey serum (Millipore-Sigma,
S30-M) in phosphate buffered saline (PBS) with 0.1% Triton X-100 at room temperature, then incu-
bated with primary antibody diluted in the blocking buffer overnight at 4˚C. Sections were washed
three times for 15 min in PBS. Secondary antibodies were diluted in blocking buffer, and brain sec-
tions were incubated in the secondary antibody solution for 2 hr at room temperature. Sections
received three 15 min washes in PBS prior to mounting on glass slides with ProLong Diamond anti-
fade mounting medium (ThermoFisher Scientific, P36965) or RIMS (refractive index matching solu-
tion; RI = 1.46) (Yang et al., 2014). VAST sections were optically cleared overnight in RIMS prior to
mounting. The following antibodies/dilutions were used: rabbit anti-tyrosine hydroxylase (EMD Milli-
pore, AB152, 1:1000; for VAST), monocloncal mouse anti-tyrosine hydroxylase (ImmunoStar, 22941,
1:1000; for TH quantification, somata tracing, and cell counting), polyclonal chicken anti-GFP (Aves,
GFP-1020, 1:1000), Alexa Fluor 488-conjugated donkey anti-chicken IgY F(ab’)two fragment (Jackson
ImmunoResearch, 703-546-155, 1:1000), Alexa Fluor 647-conjugated donkey anti-rabbit IgG Fab
fragment (Jackson ImmunoResearch, 711-606-152, 1:1000), and Alexa Fluor 647-conjugated donkey
anti-mouse IgG Fab fragment (Jackson ImmunoResearch, 711-607-003, 1:1000). Histological images
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were obtained using either a Keyence BZ-X fluorescence microscope or Zeiss 880 confocal micro-
scope. Images were analyzed using BZ-X Analyzer software (Keyence Corporation), ImageJ, and/or
Imaris (Bitplane). VTA and SNc cell counting was performed on 100 mm, coronal histological sections
from Bregma  3.2 to  3.6 mm (AP) and averaged across sections within each mouse.
Statistical analysis
Statistical analysis was performed using Matlab (MathWorks, Inc) and GraphPad Prism 7 (GraphPad
Software, Inc). All statistical tests performed on data presented in the manuscript are stated in the
figure captions and provided in detail in Source data 1. For each experiment, statistical tests were
chosen based on the structure of the experiment and data set. No outliers were removed during sta-
tistical analysis. Sample sizes estimates were based on published behavioral and electrophysiological
literature that utilized the 129T2/SvEmsJ::C57Bl/6NTac Nf1+/- mouse model; this was within a range
commonly employed by researchers in our field using similar techniques and that which was deter-
mined via the sampsizepwr() function in Matlab. Parametric tests were used throughout the manu-
script; for sIPSC and ESPC data, non-parametric Mann Whitney U tests were also reported because
sIPSC frequency was non-normally distributed for both genotypes (as determined by the D’Agostino
and Pearson normality test). In this case, the results of parametric and non-parametric hypothesis
tests were congruent (see Figure 3 caption). When analysis of variance (ANOVA; one-way, two-way,
and/or repeated measures) was performed, multiple comparisons were corrected using the Bonfer-
roni correction. Multiple t-tests were corrected with the two-stage linear step-up procedure of Ben-
jamini, Krieger and Yekutieli with a false discovery rate of 5%.
Data and materials availability
Viral vector plasmids used in this study are available on Addgene at http://www.addgene.org/Viv-
iana_Gradinaru/. Codes used for fiber photometry signal extraction and analysis are available at
https://github.com/GradinaruLab/dLight1. Source data is available at www.doi.org/10.7303/
syn18904024.
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Data availability
Viral vector plasmids used in this study are available on Addgene at http://www.addgene.org/Viv-
iana_Gradinaru/. Codes used for fiber photometry signal extraction and analysis are available at
https://github.com/GradinaruLab/dLight1. Source data is available at https://doi.org/10.7303/
syn18904024.
The following dataset was generated:
Author(s) Year Dataset title Dataset URL
Database and
Identifier
Robinson JE,
Coughlin GM, Hori
AM, Cho JR,
Mackey ED, Turan
Z, Patriarchi T, Tian
L, Gradinaru V
2019 Source Data: Optical dopamine
monitoring with dLight1 reveals
mesolimbic phenotypes in a mouse
model of neurofibromatosis type 1
https://doi.org/10.7303/
syn18904024
Synapse, 10.7303/
syn18904024
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